FindTrial
Sign In

Effect and cost-benefit analysis of active screening combined with pre-isolation intervention in preventing multidrug-resistant bacteria infection in burn ICU patients

Effect and cost-benefit analysis of active screening combined with pre-isolation intervention in preventing multidrug-resistant bacteria infection in burn ICU patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063163
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn injury

Interventions

Experimental group:Active screening combined with pre-isolation intervention mode based on routine use of daily target monitoring and hospital infection prevention and control measures
Conrol group:Daily target monitoring + standard prevention

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients admitted to the BICU within 24 hours of the burn.

Exclusion criteria

Exclusion criteria: 1. Patients admitted to the hospital with BICU < 24h were transferred, discharged automatically or died; 2. Patients who have been confirmed to be infected with multidrug-resistant organism (MDRO) upon admission to BICU; 3. A history of long-term use of hormones or immunosuppressive drugs before injury, and a history of immunosuppressive diseases; 4. Patients with incomplete data due to failure to adhere to systematic treatment.

Design outcomes

Primary

MeasureTime frame
bacteria;—

Countries

China

Contacts

Public ContactLi Lin

Fujian Medical University Union Hospital

leny2002718@163.com+86 13365918272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026